Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design.
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design. Chem Biol. 2006 Feb; 13(2):201-11.
View in:
PubMed
subject areas
Crystallography, X-Ray
Cyclin-Dependent Kinase 2
Drug Design
Enzyme Inhibitors
Models, Molecular
Molecular Structure
authors with profiles
Campbell McInnes